RVNC

Revance Therapeutics, Inc.
RVNC

Overview Fund Activity
Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

114 hedge funds and large institutions have $564M invested in Revance Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 17 closing their positions.

Holders
114
Holders Change
+2
Holders Change %
+1.79%
% of All Funds
2.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
43
Reduced
25
Closed
17
Calls
$740K
Puts
$1.46M
Net Calls
-$722K
Net Calls Change
-$919K

Top Buyers

1
ACH
1
ArrowMark Colorado Holdings
Colorado
$55.9M
2
RHJA
2
Rice Hall James & Associates
California
$11.5M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$17.3M
4
Jacobs Levy Equity Management
4
Jacobs Levy Equity Management
New Jersey
$3.1M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$2.64M

Top Sellers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$31.3M
2
Morgan Stanley
2
Morgan Stanley
New York
$79K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$470K
4
Citadel Advisors
4
Citadel Advisors
Florida
$1.86M
5
Goldman Sachs
5
Goldman Sachs
New York
$696K
Name Holding Trade Value Shares
Change 		Shares
Change %
IP
126
Intellectus Partners
California
– -$32K -2,000 Closed
QCG
127
Quadrant Capital Group
Ohio
– -$23K -1,478 Closed
WAS
128
Winch Advisory Services
Wisconsin
– -$3K -200 Closed
2 3 4 5
6